front |1 |2 |3 |4 |5 |6 |7 |8 |9 |10 |11 |12 |13 |14 |15 |16 |17 |18 |19 |20 |21 |22 |review |
Other recommended texts:
1. Steinberg SM et alii. Prognostic indicators of colon tumors: the Gastrointestinal Tumor Study Group Experience. Cancer 57(9): 1886-70, 1986. 2. Bruinvels DJ et alii: Follow up of patients with colorectal cancer: a meta-analysis. Annals of Surgery 219(2): 174-82, 1994. 3. Filela X et alii: Prognostic value of CA 19.9 levels in colorectal cancer. Annals of Surgery 216(1):55-9, 1992. 4. Fitzgerald SD et alii: Advanced colorectal neoplasia in the high-risk elderly patient: is surgical resection justified ? Diseases of the Colon and Rectum 36(2): 161-6, 1993. 5. American Society of Clinical Oncology: clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. Journal of Clinical Oncology 14(10):2843-77, 1996. 6. Mandel JS et alii: Reducing mortality from colorretal cancer by screening for fecal occult blood - the Minnesota Colon Cancer Control Study. N Engl J Med May 13;328(19):1365-71, 1993. 7. Kronborg O et alii: Randomised study of screening for colorretal cancer with faecal-occult-blood-test. Lancet Nov 30;348(9040):1467-71, 1996. 8. Hardcastle JD et alii: Randomised controlled trial of faecal-occult-blood screening for colorretal cancer. Lancet Nov 30;348(9040):1472-7, 1996. 9. Mandel JS et alii: Colorectal cancer mortality: effectiveness of biennal screening for fecal occult blood. J Natl Cancer Inst Mar 3;91(5):434-7, 1999. |